Search

Royalty Pharma PLC (Class A)

Open

SectorHealthcare

58.1 -0.27

Overview

Share price change

24h

Current

Min

57.65

Max

58.48

Key metrics

By Trading Economics

Income

-589M

-295M

Sales

44M

674M

P/E

Sector Avg

31.419

55.725

EPS

1.32

Dividend yield

1.56

Profit margin

-43.713

Employees

100

EBITDA

-387M

176M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+12.74% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.56%

2.25%

Next Earnings

4 Nov 2026

Next Dividend date

9 Dec 2026

Next Ex Dividend date

13 Nov 2026

Market Stats

By TradingEconomics

Market Cap

848M

34B

Previous open

58.37

Previous close

58.1

News Sentiment

By Acuity

15%

85%

11 / 339 Healthcare

Royalty Pharma PLC (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

24 Sept 2026, 19:25 UTC

Royalty Pharma PLC shares are rising, reflecting notable market strength, although they remain below the 20-day moving average and near the one-month range's lower end.

23 Sept 2026, 19:51 UTC

Royalty Pharma PLC shares fell sharply, reaching a session low just before 1 PM, as the broader market declines and remains below its 20-day moving average.

22 Sept 2026, 20:06 UTC

Correlated Moves

Royalty Pharma PLC is trading higher, likely influenced by Amgen Inc.'s positive Phase 3 OASIZ 301 study results, despite earlier pulling back from a session high.

21 Sept 2026, 20:06 UTC

Royalty Pharma PLC's shares are trading roughly flat, remaining below the 20-day moving average and near the lower end of their one-month range.

18 Sept 2026, 20:06 UTC

Royalty Pharma PLC shares fell sharply on Friday, closing significantly below its 20-day moving average and near the lower end of its one-month range.

17 Sept 2026, 23:06 UTC

Royalty Pharma PLC declined in after-market trading, moving lower since Thursday's close and positioning it below its 20-day moving average.

16 Sept 2026, 23:06 UTC

Royalty Pharma PLC is trading lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 Sept 2026, 23:16 UTC

News

Royalty Pharma announced a $7.5 million donation to Blood Cancer United. Shares are lower in after-market trading amid rising Treasury yields.

14 Sept 2026, 20:07 UTC

Royalty Pharma PLC shares are higher today, reflecting a modest gain since Friday. Broader market concerns over rising crude oil prices may be influencing sentiment.

11 Sept 2026, 20:08 UTC

Royalty Pharma PLC shares are lower today, pulling back from earlier gains amid broader market dynamics and inflation pressures influencing Federal Reserve policy.

10 Sept 2026, 23:46 UTC

Royalty Pharma PLC shares are higher in after-market trading, continuing a rise since Thursday's close, though still below the 20-day moving average.

9 Sept 2026, 20:07 UTC

News

Royalty Pharma shares lower today, following a decline after Novartis' trial failure. Analysts suggest the drop may be overdone amid stable royalty expectations.

8 Sept 2026, 21:01 UTC

Royalty Pharma PLC shares are higher in after-market hours, reflecting broader market dynamics despite no specific company news identified.

5 Sept 2026, 00:01 UTC

News

Royalty Pharma PLC shares fell in after-market hours following the failed Phase 3 trial of pelacarsen, impacting its funding agreement with Ionis.

4 Sept 2026, 22:14 UTC

Royalty Pharma PLC shares are trading lower during after-market hours, breaking a trend of higher daily closes. No specific news was identified for the decline.

3 Sept 2026, 23:05 UTC

Royalty Pharma PLC shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2 Sept 2026, 23:06 UTC

Royalty Pharma PLC shares are lower in after-market hours, reflecting a slight decline since Wednesday's close, despite earlier recovery attempts.

1 Sept 2026, 20:09 UTC

Royalty Pharma PLC is rising as strength in the pharmaceuticals sub-sector boosts shares. The stock remains near its one-month high despite a recent pullback.

31 Aug 2026, 23:16 UTC

Royalty Pharma PLC shares are higher in after-market trading, reflecting positive market sentiment. The stock remains near the upper end of its one-month trading range.

28 Aug 2026, 20:07 UTC

Royalty Pharma PLC shares are lower today amid broader market declines and rising U.S. Treasury yields, reflecting ongoing volatility in the pharmaceuticals sector.

27 Aug 2026, 23:11 UTC

Royalty Pharma PLC shares are higher in after-market trading, supported by a favorable performance backdrop and positioning above the 20-day moving average.

26 Aug 2026, 23:16 UTC

Royalty Pharma PLC shares are higher in after-market trading, currently above their 20-day moving average and near the upper end of their one-month range.

25 Aug 2026, 20:07 UTC

Royalty Pharma PLC shares are higher today, continuing an upward trend since Monday. Lower Treasury yields are supporting investor sentiment in the market.

24 Aug 2026, 20:06 UTC

Royalty Pharma PLC shares are near unchanged as market sentiment is influenced by rising oil prices and geopolitical tensions from new U.S. sanctions against Iran.

21 Aug 2026, 19:26 UTC

Royalty Pharma PLC shares are higher, reflecting a broader rebound in U.S. stocks amid economic uncertainties and rising inflation. The asset remains above its 20-day moving average.

20 Aug 2026, 23:11 UTC

Royalty Pharma PLC shares are lower in after-market hours, continuing a decline from earlier in the session amid mixed broader market sentiment.

19 Aug 2026, 20:02 UTC

Royalty Pharma PLC shares are higher today, driven by strong investor interest in pharmaceuticals and unusually high market volume during regular trading hours.

18 Aug 2026, 23:21 UTC

Royalty Pharma PLC shares are higher in after-market trading, continuing an upward trend from previous sessions. No specific news was identified for this movement.

17 Aug 2026, 19:36 UTC

Royalty Pharma PLC shares are trading higher during Monday's session, recovering from an earlier dip and remaining above the 20-day moving average.

15 Aug 2026, 00:01 UTC

Royalty Pharma PLC shares are lower in after-market hours, continuing a routine decline since Friday's close amid mixed global equity market performance.

Peer Comparison

Price change

Royalty Pharma PLC (Class A) Forecast

Price Target

By TipRanks

12.74% upside

12 Months Forecast

Average 65.714 USD  12.74%

High 70 USD

Low 62 USD

Based on 7 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Sentiment

By Acuity

11 / 339 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Royalty Pharma PLC (Class A)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.